on ABIVAX (EPA:ABVX)
BlackRock Reduces its Stake in ABIVAX
On November 16, 2026, BlackRock, Inc., acting on behalf of various clients and funds, crossed below the 5% threshold of ABIVAX's share capital and voting rights. Following the sale, BlackRock holds 4,245,480 shares, representing 4.85% of the share capital and 4.78% of the voting rights.
This change results from the sale of ABIVAX shares on the market and a reduction in the number of shares held as collateral. The total number of ABIVAX shares is now 87,541,485, representing 88,796,742 voting rights. Despite this reduction, BlackRock remains a significant shareholder in ABIVAX.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news